The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas
Open accessAbstract
Objective: Differences in gastric cancer (GC) clinical outcomes between patients in Asian and non-Asian countries has been historically attributed to variability in clinical management. However, recent international Phase III trials suggest that even with standardised treatments, GC outcomes differ by geography. Here, we investigated gene expression differences between Asian and non-Asian GCs, and if these molecular differences might influence clinical outcome. Design: We compared gene expression profiles of 1016 GCs from six Asian and three non-Asian GC cohorts, using a two-stage meta-analysis design and a novel biostatistical method ( RUV-4 ) to adjust for technical variation between cohorts. We further validated our findings by computerised immunohistochemical analysis on two independent tissue microarray (TMA) cohorts from Asian and non-Asian localities (n=665). Results: Gene signatures differentially expressed between Asians and non-Asian GCs were related to immune function and inflammation. Non-Asian GCs were significantly enriched in signatures related to T-cell biology, including CTLA-4 signalling. Similarly, in the TMA cohorts, non-Asian GCs showed significantly higher expression of T-cell markers (CD3, CD45R0, CD8) and lower expression of the immunosuppressive T-regulatory cell marker FOXP3 compared to Asian GCs (p<0.05). Inflammatory cell markers CD66b and CD68 also exhibited significant cohort differences (p<0.05). Exploratory analyses revealed a significant relationship between tumour immunity factors, geographic locality-specific prognosis, and postchemotherapy outcomes. Conclusions: Analyses of >1600 GCs suggest that Asian and non-Asian GCs exhibit distinct tumour immunity signatures related to T-cell function. These differences may influence geographical differences in clinical outcome, and the design of future trials particularly in immuno-oncology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
Shojaei, F., Wu, X., Malik, A. K., Zhong, C., Baldwin, M. E., Schanz, S., Fuh, G., Gerber, H.-P., & Ferrara, N. (2007) · Nature Biotechnology · doi:10.1038/nbt1323 · Cited by 849
Using control genes to correct for unwanted variation in microarray data
Gagnon-Bartsch, J. A., & Speed, T. P. (2012) · Biostatistics · doi:10.1093/biostatistics/kxr034 · Cited by 442
Self-citation
Cited by
Kang, Y.-K., Boku, N., Satoh, T., Ryu, M.-H., Chao, Y., Kato, K., Chung, H. C., Chen, J.-S., Muro, K., Kang, W. K., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31827-5 · Cited by 2,252
Self-citationGenetics and Molecular Pathogenesis of Gastric Adenocarcinoma
Tan, P., & Yeoh, K.-G. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.059 · Cited by 492
Self-citationWang, F., Wei, X. L., Wang, F. H., Xu, N., Shen, L., Dai, G. H., Yuan, X. L., Chen, Y., Yang, S. J., Shi, J. H., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz197 · Cited by 455
Molecular classification of gastric cancer
Chia, N.-Y., & Tan, P. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw040 · Cited by 375
Self-citationNakamura, Y., Kawazoe, A., Lordick, F., Janjigian, Y. Y., & Shitara, K. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00492-2 · Cited by 298
Metadata
- Authors
- Lin, S. J., Gagnon-Bartsch, J. A., Tan, I. B., Earle, S., Ruff, L., Pettinger, K., Ylstra, B., van Grieken, N., Rha, S. Y., Chung, H. C., Lee, J.-S., Cheong, J. H., Noh, S. H., Aoyama, T., Miyagi, Y., Tsuburaya, A., Yoshikawa, T., Ajani, J. A., Boussioutas, A., Yeoh, K. G., Yong, W. P., So, J., Lee, J., Kang, W. K., Kim, S., Kameda, Y., Arai, T., zur Hausen, A., Speed, T. P., Grabsch, H. I., & Tan, P.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2014-11-10
- Volume
- 64
- Issue
- 11
- Pages
- 1721-1731
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2150024391
- Cited by
- 229
- References
- 4
- FWCI
- 13.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas. https://app.cochat.ai/papers/10.1136/gutjnl-2014-308252
- The paper
- Lin, S. J., Gagnon-Bartsch, J. A., Tan, I. B., Earle, S., Ruff, L., Pettinger, K., Ylstra, B., van Grieken, N., Rha, S. Y., Chung, H. C., Lee, J.-S., Cheong, J. H., Noh, S. H., Aoyama, T., Miyagi, Y., Tsuburaya, A., Yoshikawa, T., Ajani, J. A., Boussioutas, A., . . . Tan, P. (2015). Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas. Gut. https://doi.org/10.1136/gutjnl-2014-308252
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.